Characterizing and understanding body weight patterns in patients treated with pregabalin.

Abstract:

OBJECTIVE:We examined patterns of weight change among patients treated with pregabalin for up to 1 year. METHODS:Patients with ≥1 pre-treatment weight measurement, ≥2 measurements in Period 1 (day 2-56), and ≥2 during Period 2 (day 57-356) were identified from pooled data of 106 studies including 43,525 patients. Seven patterns were developed and used for exploratory 'change point' analyses (day on-treatment when weight-change trend changed from initial trajectory) and to assess patterns of weight change by baseline weight/body mass index (BMI). RESULTS:A total of 3187 patients (from 41 studies) were eligible. 98.9% of patients were described by three of the seven patterns. The majority of patients (2607/3187 [81.8%]) remained within ±7% of baseline weight ('Pattern 4'). Fewer patients (463/3187 [14.5%]) were 'delayed weight gainers' (exceeded 7% weight gain in Period 2 but not Period 1 ['Pattern 6']), fewer still (82/3187 [2.6%]) were 'early weight gainers' (exceeded ≥7% baseline weight in Period 1 and remained above 7% or continued to gain weight in Period 2 ['Pattern 7']). Overall weight gainers (Patterns 6, 7) experienced 1-year weight gain (median [% change]) of +6.20 kg [+9.12%] and 5.46 kg [+13.9%] vs. 2.22 kg [+2.10%] for non-weight gainers (Pattern 4). Average baseline weight/BMI was lower for weight gainers (Patterns 6, 7) versus other patterns. Early weight gainers (Pattern 7) had change point day at day 40 versus day 54 for Pattern 4 and day 69 for Pattern 6. Use of concomitant medications and influence of comorbid conditions on weight should be considered as inherent variables when interpreting the study. CONCLUSIONS:The majority of patients treated with pregabalin (150-600 mg/day) for 1 year maintained weight within ±7% baseline weight. One in six patients gained ≥7% weight from baseline, and generally exceeded 7%, 2-12 months after treatment onset.

journal_name

Curr Med Res Opin

authors

Cabrera J,Emir B,Dills D,Murphy TK,Whalen E,Clair A

doi

10.1185/03007995.2012.684044

subject

Has Abstract

pub_date

2012-06-01 00:00:00

pages

1027-37

issue

6

eissn

0300-7995

issn

1473-4877

journal_volume

28

pub_type

杂志文章,meta分析
  • Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.

    abstract:OBJECTIVES:To compare the efficacy and safety of ciprofloxacin 0.3%/dexamethasone 0.1% (CIP/DEX) otic suspension with that of neomycin 0.35%/polymyxin B 10,000 IU/mL/hydrocortisone 1.0% (N/P/H) otic suspension in patients with acute otitis externa (AOE). STUDY DESIGN:Randomized, observer-masked, parallel-group, multic...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079902125004312

    authors: Roland PS,Pien FD,Schultz CC,Henry DC,Conroy PJ,Wall GM,Garadi R,Dupre SJ,Potts SL,Hogg LG,Stroman DW,Ciprodex Otic AOE Study Group.

    更新日期:2004-08-01 00:00:00

  • Pulmonary oil micro-embolism (POME) syndrome: a review and summary of a large case series.

    abstract::The use of steroid compounds formulated in oil for depot injection can be associated with acute pulmonary reactions characterized primarily by cough, but sometimes with other associated symptoms. The pathophysiology of these reactions remains unclear, although they are reported in the literature as 'POMEs' or pulmonar...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2015.1012254

    authors: Meyer RJ,Mann M

    更新日期:2015-04-01 00:00:00

  • GABA agonist: clomethiazole.

    abstract::Neuroprotective agents inhibit reactions in the brain ischaemic injury cascade which lead to neuronal death. Gamma-aminobutyric acid (GABA) is a naturally occurring inhibitory neurotransmitter that increases chloride influx into the neuron and counteracts the toxic effects of glutamate. Clomethiazole is a GABA(A) agon...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1185/030079902125000651

    authors: Vaishnav A,Lutsep HL

    更新日期:2002-01-01 00:00:00

  • Comparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia.

    abstract:OBJECTIVE:To demonstrate the equivalent efficacy of temazepam 7.5 mg and temazepam 15 mg for the treatment of transient insomnia. RESEARCH DESIGN AND METHODS:This was a double-blind, parallel group, multicenter study. Healthy male and female subjects with previous but not current complaints of transient insomnia were ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079904125003151

    authors: Erman MK,Loewy D,Scharf MB

    更新日期:2004-04-01 00:00:00

  • Modelling the resource implications and budget impact of new reimbursement guidelines for the management of cow milk allergy in Finland.

    abstract:OBJECTIVE:To assess the impact of the decision by Kela (The Social Insurance Institution) to adopt guidelines for the management of food allergies in children, developed by the Finnish Medical Society Duodecim, as the basis for reimbursing clinical nutrition preparations for the treatment of cow milk allergy (CMA) in F...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079908x280455

    authors: Guest JF,Valovirta E

    更新日期:2008-04-01 00:00:00

  • Recent advances in breast cancer: the 27th ESMO Congress 2002.

    abstract::Breast cancer was the focus of several presentations during the 27th European Society of Medical Oncology (ESMO) Congress held in Nice. Fulvestrant seems to be equally effective to tamoxifen as a first-line therapy in hormone-sensitive advanced breast cancer in postmenopausal women. However, it may be more effective t...

    journal_title:Current medical research and opinion

    pub_type:

    doi:

    authors: Mokbel K

    更新日期:2003-01-01 00:00:00

  • Lorazepam as a sedative-amnesic in an intensive care unit.

    abstract::A clinical study was carried out to evaluate the usefulness of intravenous lorazepam, given for sedation instead of opiate narcotics or diazepam, in 25 seriously-ill patients being treated in a respiratory and intensive care unit. All but 3 patients were on assisted ventilation. Standard doses of 4 mg lorazepam were g...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007997609109320

    authors: Dundee JW,Johnston HM,Gray RC

    更新日期:1976-01-01 00:00:00

  • Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses.

    abstract:OBJECTIVE:The stratum corneum (SC) pharmacokinetics of terbinafine following single-dose administration of a novel cutaneous solution (film-forming solution, FFS) containing terbinafine hydrochloride and a film-forming agent, was investigated in three studies. Terbinafine 1% cream (Lamisil) was included as a benchmark ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1185/030079907X199664

    authors: Kienzler JL,Queille-Roussel C,Mugglestone C,Ortonne JP,Larnier C

    更新日期:2007-06-01 00:00:00

  • Treating anaemia with epoetin alfa is associated with improvements in quality of life in cancer patients receiving chemotherapy.

    abstract::Anaemia is an important factor in the fatigue experienced by many patients receiving chemotherapy. A recent large-scale, randomised, placebo-controlled trial has shown that treatment with epoetin alfa raises haemoglobin levels, reduces fatigue and improves overall quality of life (QoL). In order to examine the relatio...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/174234305X13798

    authors:

    更新日期:2005-01-01 00:00:00

  • Rapid onset of action of oral labetalol in severe hypertension.

    abstract::Nine patients with persistently elevated diastolic blood pressure, exceeding 130 mmHg, received an oral dose of labetalol ranging from 200 mg to 400 mg. In all patients, this produced a significant and gradual decline in recumbent systolic and diastolic blood pressure, unaccompanied by symptoms or complications, with ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007997709110155

    authors: Ghose RR,Sampson A

    更新日期:1977-01-01 00:00:00

  • The clinical diagnosis of influenza.

    abstract::Effective management of influenza depends on early recognition of influenza in the community and on rapid diagnosis. Early recognition is achieved by integrated clinical and laboratory based surveillance programmes in representative populations. The recent introduction of 'near patient tests' for influenza provide inc...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079902125000921

    authors: Fleming D,Wood M

    更新日期:2002-01-01 00:00:00

  • The safety of cefuroxime and gentamicin in patients with reduced renal function.

    abstract::The glomerular and tubular function of 7 patients with a spectrum of renal impairment was measured before, during and after 4-days' treatment with cefuroxime and gentamicin. Neither the mean plasma urea nor creatinine concentrations of the group increased after combined treatment, nor was the excretion of cefuroxime s...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007998009109458

    authors: Cockram CS,Richards P,Bax RP

    更新日期:1980-01-01 00:00:00

  • Treatment priorities and current prescribing patterns in hypertension: results of GRASP, an international physician survey.

    abstract::The GRASP (Global Research on Attitudes about hypertension and Stroke Prevention) survey, conducted in 11 countries and involving 825 physicians, was designed to investigate physician perceptions and priorities in the treatment of hypertension and influences on choice of antihypertensive therapy. The prevention of str...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079904125004231

    authors: Volpe M,Machado E

    更新日期:2004-07-01 00:00:00

  • The prevalence, correlates and treatment of pain in the European Union.

    abstract:OBJECTIVES:To report on the results of a recent large-scale, internet-based survey of the population, prevalence and attributes of pain experience in the United Kingdom (UK), France, Spain, Germany and Italy. METHODS:The results reported here are taken from the internet-based, 2008 National Health and Wellness Survey ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2010.542136

    authors: Langley PC

    更新日期:2011-02-01 00:00:00

  • Clinical burden of venous thromboembolism.

    abstract:BACKGROUND:Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism (PE), is a major cause of morbidity and mortality. VTE is a common disorder, with an estimated annual incidence of approximately 5-12 persons per 10,000. The prognosis for patients who develop VTE is exacerbated by the r...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2010.516090

    authors: Ruppert A,Lees M,Steinle T

    更新日期:2010-10-01 00:00:00

  • Clinical evaluation of fenticonazole cream in cutaneous fungal infections: a comparison with miconazole cream.

    abstract::A randomized, double-blind, parallel-group, multi-centre clinical trial was undertaken in 60 patients with dermatophytosis or pityriasis versicolor to compare topical 2% fenticonazole cream with topical 2% miconazole cream. Treatment, by twice-daily application, was for 4 weeks or until earlier complete resolution of ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998609110427

    authors: Athow-Frost TA,Freeman K,Mann TA,Marks R,Vollum D,Warin AP

    更新日期:1986-01-01 00:00:00

  • A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease.

    abstract:OBJECTIVE:To compare injection site pain of subcutaneous (sc) epoetin beta and darbepoetin alfa in adult patients with chronic kidney disease. RESEARCH DESIGN AND METHODS:This was a multi-centre, randomised, two-arm, single-blind, cross-over study. Patients were randomised to receive weekly sc darbepoetin alfa 30 mug ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/03007990802240552

    authors: Roger SD,Suranyi MG,Walker RG,Disney A,Isbel NM,Kairaitis L,Pollock CA,Brown FG,Chow J,Truman MI,Ulyate KA,COMFORT study group.

    更新日期:2008-08-01 00:00:00

  • Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational, randomised, double-blind study. Cerivastatin Study Group.

    abstract::Elevated serum cholesterol level is a key risk factor for cardiovascular morbidity and mortality. Cerivastatin is a highly effective lipid-lowering agent currently licensed at doses of 0.1, 0.2, 0.3 and 0.4 mg. This was a multicentre, randomised, double-blind, parallel-group study comparing the efficacy and safety of ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007999909114095

    authors: Ose L,Luurila O,Eriksson J,Olsson A,Lithell H,Widgren B

    更新日期:1999-01-01 00:00:00

  • Clinical efficacy and tolerability of tenoxicam in African patients with osteoarthritis, rheumatoid arthritis, tendinitis and/or bursitis: an open study.

    abstract::An open clinical evaluation was carried out in 736 African out-patients suffering from rheumatic and inflammatory disorders to assess the efficacy and tolerability of tenoxicam in relieving the signs and symptoms of their condition. On entry, all previous treatment was discontinued and patients received a simple daily...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1185/03007999109111519

    authors: Ibrahima K,Kodjo G,Issa S,Seye L,Cisse F,Eassey G,Rietiker S

    更新日期:1991-01-01 00:00:00

  • Overactive bladder in women: symptom impact and treatment expectations.

    abstract:OBJECTIVE:The objectives of this survey were to understand (1) the effects of overactive bladder (OAB) and urinary incontinence (UI) on women's lives and to understand (2) women's needs and expectations of health care providers and treatment related to these disorders. METHODS:Women (N = 1046) with self-reported sympt...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079905X59076

    authors: MacDiarmid S,Rosenberg M

    更新日期:2005-09-01 00:00:00

  • Pegvaliase: a novel treatment option for adults with phenylketonuria.

    abstract:OBJECTIVE:In May 2018, the US Food and Drug Administration approved pegvaliase-pqpz (Palynziq*), the first enzyme substitution therapy for the treatment of phenylketonuria (PKU). This article provides an overview of the mechanism of action, pharmacokinetic properties, clinical efficacy, and the safety and tolerability ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2018.1528215

    authors: Mahan KC,Gandhi MA,Anand S

    更新日期:2019-04-01 00:00:00

  • Strategies for improving dabigatran adherence for stroke prevention in patients with non-valvular atrial fibrillation: education and drug intake reminders (FACILITA study).

    abstract::Objective To assess the efficacy of a mixed intervention, educational, and reminder calendar of the intake, as a strategy to improve therapeutic adherence with dabigatran in patients with non-valvular atrial fibrillation (NVAF). Methods This was a prospective, longitudinal, multi-center study, carried out in 110 speci...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1080/03007995.2018.1435519

    authors: Márquez-Contreras E,Martell-Claros N,Márquez-Rivero S,Hermida-Campa E,Gracia-Diez C,Sanchez-López E,Gil-Guillén V,Compliance and Inertia Working Group, Spanish Society of Hypertension (SEH-LELHA).

    更新日期:2018-07-01 00:00:00

  • Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men.

    abstract:OBJECTIVE:This study evaluated the long-term cost-effectiveness of atorvastatin 20 mg, rosuvastatin 10 mg and simvastatin 40 mg in primary and secondary prevention of CHD in Finland. RESEARCH DESIGN AND METHODS:The effect of statin therapy on the incidence of CHD and the expected total costs of the disease were descri...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990802144705

    authors: Peura P,Martikainen J,Soini E,Hallinen T,Niskanen L

    更新日期:2008-06-01 00:00:00

  • Prevalence of gastroprotective agent (GPA) use in adults with arthritis in the United States.

    abstract:OBJECTIVE:The prevalence of non-steroidal anti-inflammatory drug (NSAID) and concurrent gastroprotective agent (GPA) use in the US is not known. As such, the prevalence of GPA use among arthritis patients taking NSAIDs was examined. METHODS:Men and women aged ≥ 40 with self-reported arthritis and members of a web-base...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007995.2013.781017

    authors: Coyne KS,Margolis MK,Cappelleri JC,Hsieh R,Essex MN,Park PW,Joshi AV

    更新日期:2013-05-01 00:00:00

  • Mapping MOS Sleep Scale scores to SF-6D utility index.

    abstract:OBJECTIVE:Deriving preference scores for the Medical Outcomes Study (MOS) Sleep Scale would enable its use in cost-utility analyses. The objective of this study was to map scores of the MOS Sleep Scale to a preference-based health-state utility index (SF-6D) scored from the SF-36 Health Survey (SF-36). RESEARCH DESIGN...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/030079907X210796

    authors: Yang M,Dubois D,Kosinski M,Sun X,Gajria K

    更新日期:2007-09-01 00:00:00

  • Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM.

    abstract:BACKGROUND:Studies have shown that many patients with type 2 diabetes do not achieve optimal glycemic control, and progression of diabetes over time requires more than one pharmacotherapy to achieve glycemic goal. OBJECTIVE:To examine the efficacy and safety of the fixed-dose combination (FDC) of pioglitazone 15 mg an...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007990903350011

    authors: Perez A,Zhao Z,Jacks R,Spanheimer R

    更新日期:2009-12-01 00:00:00

  • Improving SAR symptoms with levocetirizine: evaluating active and placebo effects in pollen challenge vs. natural exposure studies.

    abstract:OBJECTIVE:Despite a plethora of published data on levocetirizine, no meta-analyses exist on the effect of study design, and covariates like age, gender, and baseline symptom severity on treatment response. The objective of this study was the efficacy of levocetirizine 5  mg tablets and matching placebo at reducing alle...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1185/03007995.2010.537319

    authors: Boev R,Song D,Bedenbaugh A,Haeusler JM

    更新日期:2011-01-01 00:00:00

  • Counting the costs of overweight and obesity: modeling clinical and cost outcomes.

    abstract:OBJECTIVE:To quantify changes in clinical and cost outcomes associated with increasing levels of body mass index (BMI) in a US setting. RESEARCH METHODS AND PROCEDURES:A semi-Markov model was developed to project and compare life expectancy (LE), quality-adjusted life expectancy (QALE) and direct medical costs associa...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X96227

    authors: Tucker DM,Palmer AJ,Valentine WJ,Roze S,Ray JA

    更新日期:2006-03-01 00:00:00

  • 'Dos and don'ts' in the management of hyponatremia.

    abstract:INTRODUCTION AND OBJECTIVE:The management of hyponatremia has evolved in recent years, particularly with the introduction of tolvaptan for hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). This commentary presents a summary of recent international recommendations in the for...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2015.1072706

    authors: Aylwin S,Burst V,Peri A,Runkle I,Thatcher N

    更新日期:2015-01-01 00:00:00

  • Conservative treatment of pelvic congestion syndrome: indications and opportunities.

    abstract:INTRODUCTION:This brief review describes conservative treatment methods for pelvic venous congestion. Therapy options: The authors present an analysis of the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs), ergot alkaloid derivatives, hormonal agents, venoprotective agents, and compression therapy in the trea...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2017.1302414

    authors: Gavrilov SG,Turischeva OO

    更新日期:2017-06-01 00:00:00